Cargando…
The key advance in the treatment of sepsis in the last 10 years ... doing less
Although many pharmaceutical and technological advances are heavily touted, they have had relatively little impact on overall outcome improvements in the critically ill. Acting on the increasing recognition that 'less may be best' has, in my opinion, been the greatest single advance in pat...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550797/ https://www.ncbi.nlm.nih.gov/pubmed/16542478 http://dx.doi.org/10.1186/cc4849 |
_version_ | 1782129275476901888 |
---|---|
author | Singer, Mervyn |
author_facet | Singer, Mervyn |
author_sort | Singer, Mervyn |
collection | PubMed |
description | Although many pharmaceutical and technological advances are heavily touted, they have had relatively little impact on overall outcome improvements in the critically ill. Acting on the increasing recognition that 'less may be best' has, in my opinion, been the greatest single advance in patient management in the intensive care unit in the past 10 years. Although certainly not qualifying as a 'brave new world' in terms of daring and exciting innovation, the importance of (often covert) iatrogenic complications should not be underestimated. |
format | Text |
id | pubmed-1550797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15507972006-08-22 The key advance in the treatment of sepsis in the last 10 years ... doing less Singer, Mervyn Crit Care Commentary Although many pharmaceutical and technological advances are heavily touted, they have had relatively little impact on overall outcome improvements in the critically ill. Acting on the increasing recognition that 'less may be best' has, in my opinion, been the greatest single advance in patient management in the intensive care unit in the past 10 years. Although certainly not qualifying as a 'brave new world' in terms of daring and exciting innovation, the importance of (often covert) iatrogenic complications should not be underestimated. BioMed Central 2006 2006-02-16 /pmc/articles/PMC1550797/ /pubmed/16542478 http://dx.doi.org/10.1186/cc4849 Text en Copyright © 2006 BioMed Central Ltd |
spellingShingle | Commentary Singer, Mervyn The key advance in the treatment of sepsis in the last 10 years ... doing less |
title | The key advance in the treatment of sepsis in the last 10 years ... doing less |
title_full | The key advance in the treatment of sepsis in the last 10 years ... doing less |
title_fullStr | The key advance in the treatment of sepsis in the last 10 years ... doing less |
title_full_unstemmed | The key advance in the treatment of sepsis in the last 10 years ... doing less |
title_short | The key advance in the treatment of sepsis in the last 10 years ... doing less |
title_sort | key advance in the treatment of sepsis in the last 10 years ... doing less |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550797/ https://www.ncbi.nlm.nih.gov/pubmed/16542478 http://dx.doi.org/10.1186/cc4849 |
work_keys_str_mv | AT singermervyn thekeyadvanceinthetreatmentofsepsisinthelast10yearsdoingless AT singermervyn keyadvanceinthetreatmentofsepsisinthelast10yearsdoingless |